Abstract
In the current situation of a pandemic caused by COVID-19 developing models accurately predicting the dynamics of the outbreaks in time and space became extremely important.
Individual-based models (IBM) simulating the spread of infection in a population have a few advantages compared to classical equation-based approach. First, they use individuals as units, which represent the population, and reflect the local variations happening in real life. Second, the simplicity of modelling the interactions between the individuals, which may not be the case when using differential equations.
We propose to use freely available population density maps to simulate the infection spread in the human population on the scale of an individual country or a city. We explore the effect of social distancing and show that it can reduce the outbreak when applied before or during peak time, but it can also inflict the second wave when relaxed after the peak. This can be explained by a large proportion of susceptible individuals, even in the large cities, after the first wave.
The model can be adapted to any spatial scale from a single hospital to multiple countries.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The University of Hertfordshire The Francis Crick Institute which receives its core funding from Cancer Research UK (FC001119), the UK Medical Research Council (FC001119), and the Wellcome Trust (FC001119).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The executable version of the described model is available for download from Zenodo DOI:10.5281/zenodo.3763585 or www.mashanov.uk
